Literature DB >> 9723552

Shortage of intravenous immunoglobulin.

H Milgrom.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9723552     DOI： 10.1016/S1081-1206(10)62792-5

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  7 in total

Review 1.  Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.

Authors:  H M Chapel
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 2.  Safety of IGIV therapy and infusion-related adverse events.

Authors:  Mark Ballow
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

4.  Pharmacokinetic and pharmacodynamic effects of high-dose monoclonal antibody therapy in a rat model of immune thrombocytopenia.

Authors:  Feng Jin; Zia R Tayab; Joseph P Balthasar
Journal:  AAPS J       Date:  2006-01-13       Impact factor: 4.009

5.  Optimization of immunoglobulin substitution therapy by a stochastic immune response model.

Authors:  Marc Thilo Figge
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

6.  Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies.

Authors:  Elena E Perez; Jacques Hébert; Anne K Ellis; Oral Alpan; William R Lumry; Ralph Shapiro; Daniel Suez; J Fernando Mandujano; Richard L Wasserman
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

7.  The role of polyclonal intravenous immunoglobulin in treating HIV-infected children with severe bacterial infections: a retrospective cohort study.

Authors:  Lyen C Huang; Landon Myer; Heather B Jaspan
Journal:  BMC Infect Dis       Date:  2008-09-24       Impact factor: 3.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.